CIK 0001139685 · <br>Emerging growth company
20/20 Biolabs, Inc.
Sign in to watch- Ticker
- AIDX
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522272107
- Phone
- 2404536339
- Business address
- 9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD, 20850
- Former names
- 20/20 GeneSystems, Inc., 20/20 GENE SYSTEMS INC
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
- 253G2 Other 253G2
Page 1 of 3 · 44 filings